RE:RE:RE:please check date on top...its sep 6It may be for another application of Photofrin. They're try to get another indication for bile duct cancer i believe. If they do get it approved it will be a long road to revenue because normal headwinds and you would have to buy an expensive laser to even treat one patient. Its a photodynamic treatment so its not just a matter of pushing pills through the system and will likely require substantial capital to get off the ground, which i don't think they'll have.
greatplay wrote: Nope; not this one; this one is about decrease of existing, which is no surprise, that's why share is not $100+;
Report was about projection annual projection ($); in addition it was talking about future new drugs for 2017 and 2018;
I googled it, even I thought, I posted it, but can't find anywhere;
It wasn't by a bull, but rather "hold" company